Pdt Partners, LLC Sangamo Therapeutics, Inc Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $29,723 - $44,480	-6,961 Reduced 10.73%	57,915 $284,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $43,597 - $82,543	13,292 Added 25.77%	64,876 $269,000
Q1 2022 May 16, 2022	BUY	$5.23 - $7.82 $43,163 - $64,538	8,253 Added 19.05%	51,584 $300,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $1.22 Million - $1.84 Million	-167,754 Reduced 79.47%	43,331 $325,000
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $336,865 - $449,029	-37,388 Reduced 15.05%	211,085 $1.9 Million
Q2 2021 Aug 16, 2021	BUY	$10.17 - $12.64 $181,981 - $226,180	17,894 Added 7.76%	248,473 $2.97 Million
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $17,984 - $28,183	-1,653 Reduced 0.71%	230,579 $2.89 Million
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $809,415 - $1.59 Million	-87,694 Reduced 27.41%	232,232 $3.62 Million
Q3 2020 Nov 16, 2020	BUY	$9.38 - $12.48 $1.46 Million - $1.94 Million	155,407 Added 94.46%	319,926 $3.02 Million
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $1.02 Million - $1.95 Million	164,519 New	164,519 $1.47 Million
Q1 2020 May 15, 2020	SELL	$5.05 - $8.85 $889,825 - $1.56 Million	-176,203 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$8.03 - $11.7 $437,032 - $636,772	-54,425 Reduced 23.6%	176,203 $1.48 Million
Q3 2019 Nov 14, 2019	BUY	$9.05 - $12.22 $2,416 - $3,262	267 Added 0.12%	230,628 $2.09 Million
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $2.02 Million - $3 Million	230,361 New	230,361 $2.48 Million
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $1.87 Million - $3.26 Million	-196,212 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $1.29 Million - $1.88 Million	-98,794 Reduced 33.49%	196,212 $3.33 Million
Q2 2018 Aug 14, 2018	SELL	$13.9 - $19.8 $2.22 Million - $3.16 Million	-159,430 Reduced 35.08%	295,006 $4.19 Million
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $287,457 - $453,562	-17,213 Reduced 3.65%	454,436 $8.63 Million
Q4 2017 Feb 14, 2018	BUY	$11.6 - $17.35 $5.47 Million - $8.18 Million	471,649	471,649 $7.74 Million

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.7M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$23.9 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11.8 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.97 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.78 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.9 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account